Skip Header

1 - 25 of 175 results for author:"Okamoto T." in Literature citations

Page of 7 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (713)

Nebulized nitrite protects rat lung grafts from ischemia reperfusion injury.

Okamoto T., Tang X., Janocha A., Farver C.F., Gladwin M.T., McCurry K.R.

J. Thorac. Cardiovasc. Surg. 0:0-0(2012) · Mapped (2)

CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis.

Sato W., Tomita A., Ichikawa D., Lin Y., Kishida H., Miyake S., Ogawa M., Okamoto T., Murata M., Kuroiwa Y. et al.

J. Immunol. 189:5057-5065(2012) · Mapped (15)

Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer.

Okamura K., Harada T., Wang S., Ijichi K., Furuyama K., Koga T., Okamoto T., Takayama K., Yano T., Nakanishi Y.

Lung Cancer 78:100-106(2012) · Mapped (5)

A cluster of interferon-gamma-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii.

Yamamoto M., Okuyama M., Ma J.S., Kimura T., Kamiyama N., Saiga H., Ohshima J., Sasai M., Kayama H., Okamoto T. et al.

Immunity 37:302-313(2012) · Mapped (4)

Platyspondylic lethal dysplasia torrance type with a heterozygous mutation in the triple helical domain of COL2A1 in two sibs from phenotypically normal parents.

Okamoto T., Nagaya K., Asai H., Tsuchida E., Nohara F., Hayashi T., Yamashita A., Nishimura G., Azuma H.

Am. J. Med. Genet. A 158A:1953-1956(2012) · Mapped (4)

The role of CD147 in the invasiveness of follicular thyroid carcinoma cells.

Omi Y., Shibata N., Okamoto T., Obara T., Kobayashi M.

Thyroid 22:383-394(2012) · Mapped (5)

Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease.

Maeda M.H., Mitsui J., Soong B.W., Takahashi Y., Ishiura H., Hayashi S., Shirota Y., Ichikawa Y., Matsumoto H., Arai M. et al.

Ann. Neurol. 71:84-92(2012) · Mapped (2)

Live-cell visualization of the trans-cellular mode of monocyte transmigration across the vascular endothelium, and its relationship with endothelial PECAM-1.

Hashimoto K., Kataoka N., Nakamura E., Hagihara K., Okamoto T., Kanouchi H., Mohri S., Tsujioka K., Kajiya F.

J Physiol Sci 62:63-69(2012) · Mapped (5)

Arabidopsis beta1,2-xylosyltransferase: substrate specificity and participation in the plant-specific N-glycosylation pathway.

Kajiura H., Okamoto T., Misaki R., Matsuura Y., Fujiyama K.

J. Biosci. Bioeng. 113:48-54(2012) · Mapped (1)

Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles.

Okamoto T., Torii S., Machida S.

J Physiol Sci 61:537-546(2011) · Mapped (5)

Functional characterization of human cyclin T1 N-terminal region for human immunodeficiency virus-1 Tat transcriptional activation.

Asamitsu K., Hibi Y., Imai K., Victoriano A.F., Kurimoto E., Kato K., Okamoto T.

J. Mol. Biol. 410:887-895(2011) · Mapped (5)

ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18.

Yamamoto M., Ma J.S., Mueller C., Kamiyama N., Saiga H., Kubo E., Kimura T., Okamoto T., Okuyama M., Kayama H. et al.

J. Exp. Med. 208:1533-1546(2011) · Mapped (3)

Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-beta and interferon-beta combined with low-dose oral steroids.

Sanvito L., Tomita A., Chihara N., Okamoto T., Lin Y., Ogawa M., Gran B., Aranami T., Yamamura T.

J. Neuroimmunol. 236:111-117(2011) · Mapped (8)

Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma.

Tamura H., Suzuki M., Moriya Y., Hoshino H., Okamoto T., Yoshida S., Yoshino I.

BMC Cancer 11:220-220(2011) · Mapped (2)

Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.

Yamazaki H., Xu C.W., Naito M., Nishida H., Okamoto T., Ghani F.I., Iwata S., Inukai T., Sugita K., Morimoto C.

Biochem. Biophys. Res. Commun. 409:14-21(2011) · Mapped (5)

The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.

Yamamura S., Matsumura N., Mandai M., Huang Z., Oura T., Baba T., Hamanishi J., Yamaguchi K., Kang H.S., Okamoto T. et al.

Int. J. Cancer 130:20-28(2012) · Mapped (9)

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

Wertz I.E., Kusam S., Lam C., Okamoto T., Sandoval W., Anderson D.J., Helgason E., Ernst J.A., Eby M., Liu J. et al.

Nature 471:110-114(2011) · Mapped (16)

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.

Chihara N., Aranami T., Sato W., Miyazaki Y., Miyake S., Okamoto T., Ogawa M., Toda T., Yamamura T.

Proc. Natl. Acad. Sci. U.S.A. 108:3701-3706(2011) · Mapped (12)

Impaired auditory-vestibular functions and behavioral abnormalities of Slitrk6-deficient mice.

Matsumoto Y., Katayama K., Okamoto T., Yamada K., Takashima N., Nagao S., Aruga J.

PLoS ONE 6:e16497-e16497(2011) · Mapped (2)

Patient reports: Two novel frameshift mutations in the SOX9 gene in two patients with campomelic dysplasia who showed long-term survival.

Okamoto T., Nakamura E., Nagaya K., Hayashi T., Mukai T., Fujieda K.

J. Pediatr. Endocrinol. Metab. 23:1189-1193(2010) · Mapped (2)

Stabilization by fusion to the C-terminus of hyperthermophile Sulfolobus tokodaii RNase HI: a possibility of protein stabilization tag.

Takano K., Okamoto T., Okada J., Tanaka S., Angkawidjaja C., Koga Y., Kanaya S.

PLoS ONE 6:E16226-E16226(2011) · UniProtKB (1)

Monocyte trans-endothelial migration augments subsequent transmigratory activity with increased PECAM-1 and decreased VE-cadherin at endothelial junctions.

Hashimoto K., Kataoka N., Nakamura E., Hagihara K., Hatano M., Okamoto T., Kanouchi H., Minatogawa Y., Mohri S., Tsujioka K. et al.

Int. J. Cardiol. 149:232-239(2011) · Mapped (5)

Deerpox virus encodes an inhibitor of apoptosis that regulates Bak and Bax.

Banadyga L., Lam S.C., Okamoto T., Kvansakul M., Huang D.C., Barry M.

J. Virol. 85:1922-1934(2011) · Mapped (8)

Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1.

Okamoto T., Matsumura N., Mandai M., Oura T., Yamanishi Y., Horiuchi A., Hamanishi J., Baba T., Koshiyama M., Shiozawa T. et al.

Mod. Pathol. 24:267-276(2011) · Mapped (2)

Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth.

Okamoto T., Inozume T., Mitsui H., Kanzaki M., Harada K., Shibagaki N., Shimada S.

Mol. Cancer Ther. 9:2333-2343(2010) · Mapped (7)

to top of page·

Page of 7 | Next »